Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-010854
Filing Date
2022-03-14
Accepted
2022-03-14 16:15:29
Documents
1
Period of Report
2022-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10023
  Complete submission text file 0000899243-22-010854.txt   11376
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Tourangeau Greg (Reporting) CIK: 0001916566 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38978 | Film No.: 22736750